Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.55
+0.02 (+1.31%)
Range 1.52 - 1.55
Open 1.55
Prev Close 1.53
52 Week 1.25 - 3.18
Volume 327209
Market Cap 798.0M
*Delayed 8/27/2014 12:45 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000